Table 2.
Effects of Interventions on Adherence Rates
Motivational Interviewing (n = 30) | Health Education (n = 32) | Pa | |||
---|---|---|---|---|---|
Mean | SD | Mean | SD | ||
MAQb | |||||
T0 (baseline) | 3.00 | 1.34 | 3.13 | 1.24 | |
T1 (posttreatment) | 3.34 | 0.99 | 3.13 | 1.12 | .34 |
T2 (6-mo follow-up) | 2.97 | 1.42 | 3.38 | 1.11 | .21 |
DAIc | |||||
T0 (baseline) | 6.86 | 2.18 | 6.03 | 2.30 | |
T1 (posttreatment) | 6.64 | 2.50 | 6.38 | 1.98 | .72 |
T2 (6-mo follow-up) | 6.89 | 2.39 | 6.67 | 2.52 | .70 |
LCS adherence score by physician and/or caregiverd | |||||
T0 (baseline) | 4.45 | 0.76 | 4.31 | 0.96 | |
T1 (posttreatment) | 4.32 | 0.84 | 4.17 | 0.81 | .74 |
T2 (6-mo follow-up) | 4.33 | 0.82 | 4.36 | 0.71 | .83 |
Note: aUnivariate analysis with baseline value as covariate.
bMAQ, medication adherence questionnaire, score ranges 0–4.
cDAI, Drug Attitude Inventory, score ranges 0–10.
dLCS, life chart schedule, score ranges 1–5.